Cargando…

Breast cancer mortality in participants of the Norwegian Breast Cancer Screening Program

BACKGROUND: The Norwegian Breast Cancer Screening Program started in 1996. To the authors' knowledge, this is the first report using individual-based data on invitation and participation to analyze breast cancer mortality among screened and nonscreened women in the program. METHODS: Information...

Descripción completa

Detalles Bibliográficos
Autores principales: Hofvind, Solveig, Ursin, Giske, Tretli, Steinar, Sebuødegård, Sofie, Møller, Bjørn
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BlackWell Publishing Ltd 2013
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4288930/
https://www.ncbi.nlm.nih.gov/pubmed/23720226
http://dx.doi.org/10.1002/cncr.28174
_version_ 1782352031452758016
author Hofvind, Solveig
Ursin, Giske
Tretli, Steinar
Sebuødegård, Sofie
Møller, Bjørn
author_facet Hofvind, Solveig
Ursin, Giske
Tretli, Steinar
Sebuødegård, Sofie
Møller, Bjørn
author_sort Hofvind, Solveig
collection PubMed
description BACKGROUND: The Norwegian Breast Cancer Screening Program started in 1996. To the authors' knowledge, this is the first report using individual-based data on invitation and participation to analyze breast cancer mortality among screened and nonscreened women in the program. METHODS: Information on dates of invitation, attendance, breast cancer diagnosis, emigration, death, and cause of death was linked by using unique 11-digit personal identification numbers assigned all inhabitants of Norway at birth or immigration. In total, 699,628 women ages 50 to 69 years without prior a diagnosis of breast cancer were invited to the program from 1996 to 2009 and were followed for breast cancer through 2009 and death through 2010. Incidence-based breast cancer mortality rate ratios (MRRs) were compared between the screened and nonscreened cohorts using a Poisson regression model. The MRRs were adjusted for calendar period, attained age, years since inclusion in the cohorts, and self-selection bias. RESULTS: The crude breast cancer mortality rate was 20.7 per 100,000 women-years for the screened cohort compared with 39.7 per 100,000 women-years for the nonscreened cohort, resulting in an MRR of 0.52 (95% confidence interval, 0.47-0.59). The mortality reduction associated with attendance in the program was 43% (MRR, 0.57; 95% confidence interval, 0.51-0.64) after adjusting for calendar period, attained age, years after inclusion in the cohort, and self-selection bias. CONCLUSIONS: After 15 years of follow-up, a 43% reduction in mortality was observed among women who attended the national mammographic screening program in Norway.
format Online
Article
Text
id pubmed-4288930
institution National Center for Biotechnology Information
language English
publishDate 2013
publisher BlackWell Publishing Ltd
record_format MEDLINE/PubMed
spelling pubmed-42889302015-01-20 Breast cancer mortality in participants of the Norwegian Breast Cancer Screening Program Hofvind, Solveig Ursin, Giske Tretli, Steinar Sebuødegård, Sofie Møller, Bjørn Cancer Original Articles BACKGROUND: The Norwegian Breast Cancer Screening Program started in 1996. To the authors' knowledge, this is the first report using individual-based data on invitation and participation to analyze breast cancer mortality among screened and nonscreened women in the program. METHODS: Information on dates of invitation, attendance, breast cancer diagnosis, emigration, death, and cause of death was linked by using unique 11-digit personal identification numbers assigned all inhabitants of Norway at birth or immigration. In total, 699,628 women ages 50 to 69 years without prior a diagnosis of breast cancer were invited to the program from 1996 to 2009 and were followed for breast cancer through 2009 and death through 2010. Incidence-based breast cancer mortality rate ratios (MRRs) were compared between the screened and nonscreened cohorts using a Poisson regression model. The MRRs were adjusted for calendar period, attained age, years since inclusion in the cohorts, and self-selection bias. RESULTS: The crude breast cancer mortality rate was 20.7 per 100,000 women-years for the screened cohort compared with 39.7 per 100,000 women-years for the nonscreened cohort, resulting in an MRR of 0.52 (95% confidence interval, 0.47-0.59). The mortality reduction associated with attendance in the program was 43% (MRR, 0.57; 95% confidence interval, 0.51-0.64) after adjusting for calendar period, attained age, years after inclusion in the cohort, and self-selection bias. CONCLUSIONS: After 15 years of follow-up, a 43% reduction in mortality was observed among women who attended the national mammographic screening program in Norway. BlackWell Publishing Ltd 2013-09-01 2013-05-29 /pmc/articles/PMC4288930/ /pubmed/23720226 http://dx.doi.org/10.1002/cncr.28174 Text en Copyright © 2013 American Cancer Society http://creativecommons.org/licenses/by/3.0/ This is an open access article under the terms of the Creative Commons Attribution License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle Original Articles
Hofvind, Solveig
Ursin, Giske
Tretli, Steinar
Sebuødegård, Sofie
Møller, Bjørn
Breast cancer mortality in participants of the Norwegian Breast Cancer Screening Program
title Breast cancer mortality in participants of the Norwegian Breast Cancer Screening Program
title_full Breast cancer mortality in participants of the Norwegian Breast Cancer Screening Program
title_fullStr Breast cancer mortality in participants of the Norwegian Breast Cancer Screening Program
title_full_unstemmed Breast cancer mortality in participants of the Norwegian Breast Cancer Screening Program
title_short Breast cancer mortality in participants of the Norwegian Breast Cancer Screening Program
title_sort breast cancer mortality in participants of the norwegian breast cancer screening program
topic Original Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4288930/
https://www.ncbi.nlm.nih.gov/pubmed/23720226
http://dx.doi.org/10.1002/cncr.28174
work_keys_str_mv AT hofvindsolveig breastcancermortalityinparticipantsofthenorwegianbreastcancerscreeningprogram
AT ursingiske breastcancermortalityinparticipantsofthenorwegianbreastcancerscreeningprogram
AT tretlisteinar breastcancermortalityinparticipantsofthenorwegianbreastcancerscreeningprogram
AT sebuødegardsofie breastcancermortalityinparticipantsofthenorwegianbreastcancerscreeningprogram
AT møllerbjørn breastcancermortalityinparticipantsofthenorwegianbreastcancerscreeningprogram